Tianda Pharmaceuticals Cash Flow Statement

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Net Income	-61.37	-24.16	-54.64	-19.77
Depreciation & Amortization	36.28	34.47	48.25	20.03
Other Amortization	1.95	1.94	2	2.12
Loss (Gain) From Sale of Assets	0.1	-0.14	-1.25	-12.03
Asset Writedown & Restructuring Costs	1.34	-	-	1.58
Loss (Gain) From Sale of Investments	-	-	0.12	0.02
Provision & Write-off of Bad Debts	-0.6	0.79	0.62	0.44
Other Operating Activities	-2.16	-4.68	-7.07	-20.04
Change in Accounts Receivable	26	33.31	-14.63	9.08
Change in Inventory	23.5	-18.9	19.23	-8.68
Change in Accounts Payable	4.85	35.48	-32.97	13.41
Change in Other Net Operating Assets	-39.6	-107.86	142.23	5.62
Operating Cash Flow	-9.7	-49.76	101.9	-8.23
Capital Expenditures	-20.61	-49.28	-33.28	-53.76
Sale of Property, Plant & Equipment	0.09	0.28	1.63	0.03
Divestitures	-	-	-	151.9
Sale (Purchase) of Intangibles	-16.88	-17	-	-
Investment in Securities	-10.86	-6.14	14.49	-13.77
Other Investing Activities	16.48	3.03	4.34	1.95
Investing Cash Flow	-31.78	-69.1	-12.81	86.35
Long-Term Debt Issued	75.92	43.46	-	33.46
Total Debt Issued	75.92	43.46	21.54	33.46
Long-Term Debt Repaid	-100.98	-70.03	-	-25.31
Total Debt Repaid	-100.98	-70.03	-36.68	-25.31
Net Debt Issued (Repaid)	-25.06	-26.58	-15.14	8.15
Common Dividends Paid	-5.59	-5.59	-23.5	-8.56
Other Financing Activities	-	-25.23	0.12	-0.89
Financing Cash Flow	-30.65	-57.39	-38.52	-1.3
Foreign Exchange Rate Adjustments	-4.63	-1.58	-42.21	8.93
Net Cash Flow	-76.75	-177.84	8.37	85.76
Free Cash Flow	-30.3	-99.04	68.63	-61.98
Free Cash Flow Margin	-9.18%	-18.61%	12.55%	-12.16%
Free Cash Flow Per Share	-0.01	-0.05	0.03	-0.03
Cash Interest Paid	4.85	4.95	6.72	-
Cash Income Tax Paid	5.96	-0.37	0.41	-
Levered Free Cash Flow	-71.25	-112.42	-	101.92
Unlevered Free Cash Flow	-68.22	-109.33	-	102.37
Change in Working Capital	14.76	-57.97	113.86	19.43

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.